Bladder Cancer Briefs January 25, 2023

Read prior editions

Bladder Cancer in the News: Update About BCG Supply

Members of the ASCO Daily News recently spoke with representatives of Merck about the supply and production of BCG. Since 2012, Merck has been the sole producer of TICE BCG in many countries, including the United States. As many bladder cancer patients have learned, over the last several years, there has been a high demand for BCG treatments and the demand exceeded the available supply.

Read the article published by ASCO Daily News to find out the latest update about BCG production.

Resources for Patients and Families

Want to know more about what BCG?

Visit BCAN’s What to Know About BCG Treatment for Bladder Cancer page and learn more. You can also listen to these Bladder Cancer Matters podcasts:

• What to Know About BCG Treatments for Bladder Cancer with Dr. Ashish Kamat and
• How Patients Can Navigate the BCG Shortage with Dr. Robert Svatek.